PATH vs PGNY
Uipath Inc (PATH) versus Progyny Inc (PGNY) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Progyny Inc (PGNY) is a healthcare plans company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported PGNY revenue for 2024-12-31 was $298.4M. Net income was $54.3M. Revenue was up 4.1% from 2024-09-30 to 2024-12-31. PGNY currently screens at market cap $1.84B and trailing P/E 37.6.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. PGNY currently screens at market cap $1.84B and trailing P/E 37.6.
Not investment advice. Open the PATH and PGNY stock pages for the full models.
Not investment advice.